Observational study of mpox in pregnancy
Part of Infections clinical trials.
This study follows pregnant women in South Kivu, DRC, to learn more about how mpox affects pregnancy. It looks at both women with mpox symptoms and those without, to better understand the virus and help improve care for mothers and babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have a positive pregnancy test or doctor's confirmation.
- You live in the South Kivu area of the Democratic Republic of Congo, near a study healthcare facility.
- You may have symptoms of mpox like fever, rash, or swollen glands, or you may have no symptoms but have been in close contact with someone who has mpox.
- You agree to take part in the study and give your informed consent (or have a parent or caregiver give permission if you are under the legal age).
- You do not have a serious medical condition (like active cancer) that could affect your immune system, and you are not planning to move away from the study area during your pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.
This study tests how well new rapid point-of-care mpox diagnostic tests work compared to standard lab tests. If you have stored mpox samples available, your samples could help validate these faster diagnostic methods.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
Hear when a new Monkey Pox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.